Navigation Links
Embryonic Stem Cell Research in the Toilet, According to Arthritis Treatment Center
Date:8/25/2010

FREDERICK, Md., Aug. 25 /PRNewswire/ -- The recent ruling by federal judge Royce C. Lamberth halting embryonic stem cell research may present a hurdle for some disease research but not necessarily for arthritis.  A key note presentation, entitled "Guided Mesenchymal Stem Cell Layering Technique for Treatment of Osteoarthritis of the Knee" will be made on November 9, 2010 at the annual meeting of the American College of Rheumatology in Atlanta.

Osteoarthritis (OA) is a disease associated with the loss of cartilage, the gristle that caps the ends of long bones and which provides cushioning and shock absorption.  When cartilage wears away, the end result is reduced joint function, and possibly, disability.

According to lead author Dr. Nathan Wei, "Osteoarthritis affects more than 20 million Americans, but our treatment options have been limited to symptom relief... No therapies solve the problem of cartilage loss."

He goes on to say, "Many people aren't aware that there are many different types of stem cells.  Embryonic cells are only one type.  Adult stem cells are readily accessible from bone marrow. Our study shows that adult stem cells may hold the key to successful cartilage regeneration. "

He adds, "We used a 'cocktail' mixture of adult stem cells, platelet rich plasma, better known as PRP, and fat.  The PRP stimulates stem cell growth and the fat provides a framework and bulk for the stem cells to hold onto."

In the study, 22 patients underwent stem cell treatment for osteoarthritis of the knee.  Data was available for 20 patients, ranging in age from 36 to 84 years.  There were 15 men and 5 women.  

Clinical assessments as well as ultrasound measurement of cartilage thickness were performed.

There were three treatment failures, defined as patients who did not improve above baseline.

Data was available at the time of abstract submission for 11 patients at 6 months and 8 patients at one year.  Significant improvements in clinical measures and cartilage thickness were demonstrated.

Dr. Wei cautions, "This was an uncontrolled study.  And, obviously further refinements of technique as well as many unanswered questions remain.  Further studies are warranted."

Dr. Wei is a board-certified rheumatologist and a regenerative medicine specialist who practices in Frederick, Maryland.

http://www.arthritistreatmentcenter.com


'/>"/>
SOURCE Arthritis Treatment Center
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Impact of Very Small Embryonic-Like Stem Cells in Regenerative Medicine is Highlighted by Five Posters and Two Oral Presentations at the 2009 American Society of Hematology Annual Meeting
2. Roundtable Calls Presidents Embryonic Stem Cell Decision: Bankrupt
3. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
4. A Functional Immune System Can Be Derived From Embryonic Stem Cells, Preliminary Study Finds
5. New Studies End Debate on Embryonic Stem Cell Research
6. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
7. Preliminary Research Results Suggest up to 70% Reduction in Dose for Positron Emission Mammography Imaging
8. International Research Team Closes In On Cause of Common Form of Muscular Dystrophy
9. Reportlinker Adds Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets
10. CVS Caremark Behavioral Change Research Partnership Presents Ongoing Research at Center for Disease Control Symposium
11. Luminex Donates Companys First MAGPIX Multiplexing System to Papua New Guinea Institute of Medical Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) (TASE: ... on the development of oral drug delivery systems, announced ... the U.S. Food and Drug Administration (FDA) regarding ORMD-0801, ... At the meeting, the FDA gave ... ORMD-0801, would be a Biologics License Application (BLA).  Such ...
(Date:8/29/2017)... , Aug. 29, 2017 ivWatch, LLC, the leading provider ... infiltrations, announced it has been awarded an Innovative Technology contract from ... the country. ... device to aid in the early detection of peripheral IV infiltration ... The Innovative Technology contract ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
(Date:9/22/2017)... ... ... “Letters From Home”: a moving compilation of letters that remind readers of the ... is the creation of published author, John Allred, a passionate leader of ministry to ... who has traveled and ministered on four continents. , “It is my hope and ...
(Date:9/21/2017)... , ... September 21, 2017 , ... With ProSlideshow Portrait ... and easy to do. Users can select from up to two layers of subject ... click of a mouse all within Final Cut Pro X. , With ...
(Date:9/21/2017)... , ... September 21, 2017 , ... ... learn with Infinity Behavioral Health Services for professionals in the addiction treatment industry ... Payer Audit . , Insurance companies and state and federal governments are ...
(Date:9/21/2017)... ... September 21, 2017 , ... Bill Howe Plumbing’s mission is to create an ... to the community. For over 37 years, they have operated with their mission at ... in San Diego. They were chosen as the Best San Diego plumber in ...
Breaking Medicine News(10 mins):